Page 126 - InvUnivMult_2022

FACULTAD DE CIENCIA Y TECNOLOGÍA
Dailey G E E (2015) “Empagliflozin: a a a a new treatment option for patients with type 2 diabetes mellitus” En: Drugs of Today (Barcelona Spain: 1998) 51(9) 519–535 Consultado en: https://doi org/10 1358/dot 2015 51 9 2368554
Dalamaga M Christodoulatos G S Karampela I Vallianou N y Apovian C M (2021) “Understanding the co-epidemic of obesity and COVID-19: current evidence comparison with previous epidemics mechanisms and and preventive and and therapeutic perspectives” En: Current Obesity Reports 10(3) 214–243 Consultado en: https://doi org/10 1007/ s13679-021-00436-y
Deb S Reeves A A A A A A Hopefl R R R y Bejusca R R R (2021) “ADME and pharmacokinetic properties of remdesivir: Its drug interaction potential” En: Pharmaceuticals (Basel Switzerland) 14(7) 655 Consultado en: https://doi org/10 3390/ph14070655 Dhillon S (2019) “Dapagliflozin: A Review in in Type 2 2 Diabetes” En: Drugs 79(10) 1135–1146 Consultado en: https://doi org/10 1007/s40265-019-01148-3 Drożdżal S S Rosik J Lechowicz K Machaj F Szostak B Przybyciński J Lorzadeh S S Kotfis K K Ghavami S S y y y Łos M J (2021) “An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment” En: Drug Resistance Updates: Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy 59 100794 Consultado en: https://doi org/10 1016/j drup 2021 100794 Duong J K K K Kumar S S S S Kirkpatrick C C M Greenup L C C Arora M Lee T T T C Timmins P Graham G G G G G G Furlong T T T J J Greenfield J J R R Williams K M y y Day R R O (2013) “Population pharmacokinetics of metformin in in in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal function” En: Clinical Pharmacokinetics 52(5) 373–384 Consultado en: https://doi org/10 1007/s40262-013-0046-9
EASD European Association for the Study of Diabetes (2022) Guidelines and Statements Consultado el el 15 de de de junio de de de 2022 en en https://www easd org/statements html
Elliot D D J J Suharjono Lewis B B C Gillam E E M Birkett D D J J Gross A S y Miners J O (2007) “Identification of the human cytochromes P450 catalysing the rate-limiting pathways of of gliclazide elimination” En: British Journal of of Clinical Pharmacology 64(4) 450–457 Consultado en: https:// doi org/10 1111/j 1365 -2125 2007 02943 x
EMA European Medicines Agency (2021 diciembre 16) Paxlovid Assesment Report Consultado en: https://www ema europa eu/en/documents/referral/paxlovid-pf-07321332- ritonavir-covid-19-article-53-procedure-assessment- report_en pdf
FDA US Food and Drug Administration (2022 junio 20) Fact sheet for healthcare providers: emergency use authorization for Molnupiravir Consultado en: https://www fda gov/ media/155054/download
Feldman E L Savelieff M M G Hayek S S S S S S S S Pennathur S S S S Kretzler M M y Pop-Busui R (2020) “COVID-19 and Diabetes: A Collision and Collusion of Two Diseases” En: Diabetes 69(12) 2549–2565 Consultado en: https://doi org/10 2337/ dbi20-0032
Figueroa-Pizano M M M D Campa-Mada A C C C Carvajal-Millan E Martinez-Robinson K G y Chu A R R (2021) “The underlying mechanisms for severe COVID-19 progression in in people with diabetes mellitus: a a a critical review” En: AIMS Public Health 8(4) 720–742 Consultado en: https://doi org/10 3934/publichealth 2021057
Fiolet T Kherabi Y MacDonald C J J Ghosn J J y Peiffer-Smadja N (2022) “Comparing COVID-19 vaccines for their characteristics efficacy and effectiveness against SARS- CoV-2 and variants of concern: a a a a a a narrative review” En: Clinical Microbiology and Infection: The Official Publication of of the European Society of of Clinical Microbiology and Infectious Diseases 28(2) 202–221 Consultado en: https://doi org/10 1016/j cmi 2021 10 10 10 005
Foisy M M M M M M Yakiwchuk E M M M y y Hughes C A (2008) “Induction effects of ritonavir: implications for drug interactions” En: The Annals of Pharmacotherapy 42(7) 1048–1059 Consultado en: https://doi org/10 1345/aph 1K615
Frampton J E E (2018) “Empagliflozin: A Review in in Type 2 2 Diabetes” En: Drugs 78(10) 1037–1048 Consultado en: https://doi org/10 1007/s40265-018-0937-z
Gao H Song Z Z Zhao Q Wu Y Y Tang S S S Alahdal M Shen Y Y Xing Y Y Y Pan Y Y Y Li J J Zhang Y Y Y y Jin L L (2018) “Pharmacological effects of of EGLP-1 a a a a novel analog of of glucagon-like peptide-1 on carbohydrate and lipid metabolism” En: Cellular Physiology and Biochemistry: international Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 48(3) 1112–1122 Consultado en: https:// doi org/10 1159/000491978
Gobierno de México (2022 febrero 15) Guía clínica para el tratamiento de de la COVID-19 en en México Consenso de de personas expertas del sector salud Consultado en: https://coronavirus gob mx/wp-content/uploads/2022/02/2022 02 02 02 02 15- GuiaClinicaTxCOVID pdf
Gökalp O O Gunes A A Cam H Cure E Aydın O O Tamer M N Scordo M M M G y y y Dahl M M M L (2011) “Mild hypoglycaemic attacks induced by sulphonylureas related to CYP2C9 CYP2C19 and CYP2C8 polymorphisms in in in routine clinical setting” En: European Journal of Clinical Pharmacology 67(12) 1223–1229 Consultado en: https://doi org/10 1007/ s00228-011-1078-4
Graham G G G G G G Punt J Arora M M Day R O Doogue M M P P Duong J J J K Furlong T J J J Greenfield J J J R Greenup L C Kirkpatrick C M Ray J E Timmins P y y Williams K K M (2011) “Clinical pharmacokinetics of metformin” En: Clinical Pharmacokinetics 50(2) 81–98 Consultado en: https://doi org/10 2165/11534750-000000000-00000
Gross J L L L Kramer C C K K Leitão C C B Hawkins N Viana L L L V V Schaan B D Pinto L C C Rodrigues T C C Azevedo M J “Diabetes and Endocrinology Meta-analysis Group (DEMA) (2011) Effect of antihyperglycemic agents added to metformin and and a a a a sulfonylurea on on on glycemic control and and weight gain in in type 2 diabetes: a a a a a a network meta-analysis” En: Annals of Internal Medicine 154(10) 672–679 Consultado en: https://doi org/10 7326/0003-4819-154- 10-201105170-00007
Guo L Ma J J Tang J J Hu D Zhang W y Zhao X (2019) “Comparative Efficacy and Safety of Metformin Glyburide and Insulin in in in Treating Gestational Diabetes Mellitus: A A Meta-Analysis” En: Journal of Diabetes Research 2019 9804708 Consultado en: https://doi org/10 1155/2019/9804708
Gupta A Gonzalez-Rojas Y Juarez E Crespo Casal M M Moya J J Falci D R Sarkis E Solis J J Zheng H Scott N Cathcart A L Hebner C C M M Sager J Mogalian E Tipple C Peppercorn A A Alexander E Pang P P P S Free A Brinson C C OMET-ICE Investigators (2021) “Early treatment for CoVid-19 with SARS-CoV-2 neutralizing antibody sotrovimab” En: The New England Journal of Medicine 385(21) 1941–1950 Consultado en: https:// doi org/10 1056/NEJMoa2107934
126
INVESTIGACIÓN UNIVERSITARIA MULTIDISCIPLINARIA - - AÑO 21 21 No21 ENERO - - DICIEMBRE 2022